Shanmuga Hospital Ltd544365Corporate

Latest results: Jun 2026 7 quarters of data

—

MCap —

Live price not available

Shanmuga Hospital Ltd — Stock analysis & AI research Shanmuga Hospital Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹12 Cr

Sales · Jun 2026

+3.4% YoY

₹2 Cr

Operating Profit · Jun 2026

+0.1% YoY

17.7%

OPM % · Jun 2026

-3.3% YoY

₹1 Cr

Net Profit · Jun 2026

+3.8% YoY

₹0.72

EPS · Jun 2026

+2.9% YoY

📝 Shanmuga Hospital Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Shanmuga Hospital Ltd reported revenue of ₹12 crore for the quarter ended June 2026 (Q1 FY27), up 3.4% from ₹11 crore in the same quarter last year, and down 48.0% sequentially over the March 2026 quarter.

Net profit rose 3.8% year-on-year to ₹1 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹0.72.

Operating profit stood at ₹2 crore — an operating margin (OPM) of 17.7%, compared with 18.3% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Shanmuga Hospital Ltd posted revenue of ₹59 crore, with a net profit of ₹5 crore.

Shareholding pattern

As of Mar 2026, promoters held 72.06%, foreign institutional investors (FIIs) 0.00%, public shareholders 27.94% of Shanmuga Hospital Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

N/A

Current Price ?

N/A

P/E ?

N/A

Industry P/E ?

N/A

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

12.6%

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹12 Cr

PAT — latest qtr ?

₹1 Cr

YoY qtr sales growth ?

3.4%

YoY qtr profit growth ?

3.8%

Sales growth (3y) ?

Sales growth (5y) ?

N/A

Profit growth (3y) ?

-4%

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹7 Cr

Debt to Equity ?

0.16

Interest Coverage ?

13.2

Current Ratio ?

N/A

Ownership

Promoter holding ?

72.06%

Change in promoter holding ?

-0.05%

Pledged percentage ?

N/A

Market

Return 3 months ?

N/A

Return 6 months ?

N/A

🗓️ Quarterly results (7 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	22	25	23	11	25	23	12	+3.4%	-48.0%
Operating Profit	4	4	4	2	5	4	2	+0.1%	-43.6%
Other Income	0	0	0	0	0	1	0	-57.3%	-91.9%
Interest	0	0	0	0	0	0	0	-9.6%	-57.2%
Depreciation	1	1	1	1	2	1	1	-7.6%	-32.6%
Profit Before Tax	3	3	2	1	3	3	1	+1.2%	-55.6%
Net Profit	2	2	2	1	2	2	1	+3.8%	-55.2%
EPS	2.53	2.44	1.33	0.70	1.48	1.62	0.72	+2.9%	-55.6%
OPM %	19.7%	18.0%	16.4%	18.3%	18.4%	16.3%	17.7%	-3.3%	+8.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY26	TTM	YoY %
Sales	—	₹59 Cr	—	—
Operating Profit	—	₹10 Cr	—	—
OPM %	—	17.60%	—	—
NPM %	—	8.76%	—	—
Other Income	—	₹1 Cr	—	—
Depreciation	—	₹4 Cr	—	—
Interest	—	₹1 Cr	—	—
EBIT	—	₹7 Cr	—	—
PBT	—	₹7 Cr	—	—
Tax	—	—	—	—
Net Profit	—	₹5 Cr	—	—
EPS	—	₹3.80	—	—
Material Cost	—	—	—	—
Employee Cost	—	—	—	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	0.08	9.80	13.61	13.61	+0.0%
Reserves	11.74	7.34	26.09	28.89	+10.7%
Borrowings	7.65	9.02	7.61	6.73	-11.6%
Other Liabilities	3.58	7.76	5.47	3.83	-30.0%
Total Liabilities	23.05	33.92	52.78	53.06	+0.5%
Fixed Assets	9.97	15.85	22.43	37.64	+67.8%
CWIP	0.00	4.34	0.00	2.44	—
Investments	0.02	0.02	0.03	0.03	+0.0%
Other Assets	13.06	13.71	30.32	12.95	-57.3%
Total Assets	23.05	33.92	52.78	53.06	+0.5%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	2.95	9.58	-12.64	12.31	+197.4%
Cash from Investing Activity	-8.31	-11.59	-4.48	-20.33	-353.8%
Cash from Financing Activity	7.37	0.90	16.39	-2.65	-116.2%
Net Cash Flow	2.00	-1.12	-0.73	-10.66	-1360.3%
Free Cash Flow	-5.32	-1.93	-17.04	-8.16	+52.1%
CFO/OP	71%	129%	-117%	159%	+235.9%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	57.64	62.53	63.98	52.78	-17.5%
Inventory Days	36.41	—	—	48.50	—
Days Payable	34.33	—	—	50.98	—
Cash Conversion Cycle	59.71	62.53	63.98	50.31	-21.4%
Working Capital Days	27.05	-12.85	67.92	38.08	-43.9%
ROCE %	51.72%	33.53%	17.20%	12.62%	-26.6%

👥 Shareholding (latest 3 periods)

Metric	Mar 2025	Sep 2025	Mar 2026	% Chg
Promoters	72.11%	72.06%	72.06%	+0.0%
FIIs	0.19%	0.00%	0.00%	—
Public	27.70%	27.94%	27.94%	+0.0%
No. of Shareholders	1,449	1,156	1,008	-12.8%

⚖️ Peer comparison

Peer comparison unavailablePeer comparison unavailable — industry and sector are not classified for this symbol.

❓ Frequently asked questions

What was Shanmuga Hospital Ltd's revenue in Q1 FY27?

What was Shanmuga Hospital Ltd's net profit in Q1 FY27?